太原市治疗长痔疮费用-【山西肛泰院】,HaKvMMCN,山西治疗有痔疮费用,太原肛瘘手术治疗费用,太原哪里看肛肠比较好,太原肛泰医院慨况,太原大便无痛有鲜血怎么回事,太原肛裂怎么形成

National news network Newsy is set to launch its new documentary series "Sold in America" this weekend. The three-part series begins on Sunday, Feb. 18 and takes a deep dive into the criminal world intersection between drug addiction and sex trafficking. The documentary features interviews with trafficking survivors, sex workers, pimps, buyers and public officials dealing with the issues. “‘Sold in America’ puts deep reporting against a backdrop of intense, memorable scenes and nuanced, sensitive storytelling to paint a new picture of the buying and selling of sex,” Christina Hartman, vice president of news and programming for Newsy, said in a news release. “You will walk away heartbroken, then angry, but ultimately inspired to influence change.”“Sold in America” premieres on Newsy’s cable and over-the-top live-streaming channels Sunday, Feb. 18, at 9 p.m. Eastern. The series can then be found for on-demand viewing beginning Thursday, Feb. 22, on streaming services including Roku, Amazon Fire TV and Apple TV. Check local listings for channel availability. Newsy is a wholly owned subsidiary of The E.W. Scripps Company, which owns this station. See the trailer below. 1233
National lab companies are offering antibody tests as part of their return to work offerings, but doctors are warning these tests shouldn't be used yet to determine whether it's safe for you to be back in an office.“There is not a perfect antibody test out there right now to determine an individual’s immunity to COVID-19,” said Dr. Susan Bailey, President of the American Medical Association. “The tests are getting better. We've come a long way in the last few months, but we're certainly not ready to do anything like give someone an immunity certificate or anything like that.Quest Diagnostics and LabCorp are two companies offering the testing to employers.LabCorp does say that antibody testing should not be used as the sole basis to diagnose or exclude COVID-19 infection.Quest Diagnostics also emphasizes it is unknown how long antibodies persist following infection, and if the presence of antibodies gives you immunity.That's something the American Medical Association agrees with.“Everything needs to be taken in context. Have you been exposed to COVID-19? How careful have you been? Have you been in any settings where you might have been inadvertently exposed?” asked Bailey. “The lab values themselves may not mean a whole lot. We still have a lot to learn when it comes to what defines immunity to COVID-19.”Bailey also points to early studies on antibodies that indicate they may not last very long. She says she's not sure antibody testing is ever going to be the way to go to determine when someone is safe to go back to work.If you do get an antibody test, it's important to go over it with your doctor so they can help you understand the significance of it.The American Medical Association says antibody tests can be helpful to try to see how many people in an area have been exposed to COVID-19, and also for determining if someone who had COVID-19 is eligible to donate plasma. 1909

More than 3,000 people died from the coronavirus on Wednesday in the United States, which is a figure higher than at any point during the spring surge of the virus.According to data compiled by Johns Hopkins University, 3,014 deaths have been reported on Wednesday. Wednesday also marked another day where reported coronavirus cases climbed above 200,000.The US is now averaging well above 2,000 coronavirus deaths per day, an average that has doubled in the last month. As of late Wednesday, more than 289,000 Americans have died since March from the coronavirus.Hospitalizations are also sharply rising. According to the COVID Tracking Project, there are currently more than 106,000 coronavirus-related hospitalizations. The COVID Tracking Project reported an increase of 2,098 active hospitalizations on Wednesday.With so many active hospitalizations, workers have been trying to make space to accommodate the surge of patients. In Nevada, workers have been treating patients in the hospital’s parking garage.Dr. Jacob Keeperman, who works in a Reno, Nevada, hospital’s ER, tweeted a photo which went viral, but also drew attention from the president, who claimed was fake.“I was sad and devastated and was angry,” Keeperman said in an interview with CNN. 1266
Moderna announced on Thursday that it had enrolled 30,000 participants in its Phase 3 COVID-19 vaccine trial, with more than 11,000 of those participants from communities of color.More than 25,650 participants have already received their second vaccination, the company said in a press release.The company added that the study also includes 7,000 participants over the age of 65.“Completing enrollment of the Phase 3 COVE study is an important milestone for the clinical development of mRNA-1273, our vaccine candidate against COVID-19," said Stéphane Bancel, Chief Executive Officer of Moderna in the news release. "We are indebted to all of the participants in the study. We would also like to thank the investigators and our partners at clinical trial sites, including our partners from PPD and the NIH, as well as the dedicated Moderna team for their support in completing enrollment. Moderna is committed to rigorous scientific research and the highest data quality standards. We will continue to work in collaboration with regulators to advance mRNA-1273, which we hope will help defeat the COVID-19 pandemic.”CNN reported that for Moderna to apply to the FDA for emergency use authorization, the following three things need to happen:53 of the 30,000 participants would need to become sick with COVID-19, which is expected to occur in the second half of November.40 of the 53 participants who do become ill with COVID-19 need to have received the placebo, which would show that the vaccine is 75% effective.Make sure enough time has passed to see if participants develop side effects.According to CNN, Moderna is the first company to start US clinical trials of a COVID-19 vaccine. 1696
MILWAUKEE -- A Milwaukee family is devastated by the sudden loss of a young man. 21-year-old Nasir Matthews collapsed and died Tuesday while playing pick-up basketball. Terrell Matthews was there as his cousin and best friend fell to the ground after a game."The second game ended, he went over to the fan, leaned over for a second and he just went out," Matthews said. "Everything started happening so fast."Matthews said at first, everyone thought he was joking around. "After about 30 seconds they all started to see his eyes were just a blank stare," Matthews said.Matthews called 911 as others tried to revive him with a defibrillator at the school. Despite their efforts, Matthews was pronounced dead a short time later."At this point, we don't know why he fell out," said Matthews' aunt Camille Rose. "He didn't have any known medical condition other than an enlarged heart." Rose said this brings another round of grieving for Matthews' younger siblings who can't seem to catch a break. "The kids were all trying to deal with the loss of their mother, their grandmother and basically their father," Rose said. Through the tears, Matthews looks back at the memories he shared with his cousin. "He was always happy, even through what he's been through," Matthews said. The tragedy serves as a painful reminder to never take a loved one for granted, no matter their age. Matthews' family is still waiting on autopsy results to find out exactly why he died. 1522
来源:资阳报